Batanopride (BMY-25801): A new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis

L. Smaldone, P. Plezia, David S Alberts, M. Aapro, G. Sartiano, M. Dorn, M. Brady, C. Comerski, S. E. Schwartz, C. Fairchild, R. Canetta, M. Rozencweig

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)319-327
Number of pages9
JournalCancer Treatment Reviews
Volume17
Issue number2-3
DOIs
StatePublished - 1990

Fingerprint

Serotonin 5-HT3 Receptor Antagonists
Receptors, Serotonin, 5-HT3
Ferrets
Serotonin Antagonists
Metoclopramide
Antiemetics
Dopamine Antagonists
Antineoplastic Agents
Cisplatin
Vomiting
Hemodynamics
Dogs
Drug Therapy
Neoplasms
batanopride

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Batanopride (BMY-25801) : A new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis. / Smaldone, L.; Plezia, P.; Alberts, David S; Aapro, M.; Sartiano, G.; Dorn, M.; Brady, M.; Comerski, C.; Schwartz, S. E.; Fairchild, C.; Canetta, R.; Rozencweig, M.

In: Cancer Treatment Reviews, Vol. 17, No. 2-3, 1990, p. 319-327.

Research output: Contribution to journalArticle

Smaldone, L, Plezia, P, Alberts, DS, Aapro, M, Sartiano, G, Dorn, M, Brady, M, Comerski, C, Schwartz, SE, Fairchild, C, Canetta, R & Rozencweig, M 1990, 'Batanopride (BMY-25801): A new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis', Cancer Treatment Reviews, vol. 17, no. 2-3, pp. 319-327. https://doi.org/10.1016/0305-7372(90)90064-M
Smaldone, L. ; Plezia, P. ; Alberts, David S ; Aapro, M. ; Sartiano, G. ; Dorn, M. ; Brady, M. ; Comerski, C. ; Schwartz, S. E. ; Fairchild, C. ; Canetta, R. ; Rozencweig, M. / Batanopride (BMY-25801) : A new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis. In: Cancer Treatment Reviews. 1990 ; Vol. 17, No. 2-3. pp. 319-327.
@article{8f7d3be0316a4bfaa18d710afb0fea10,
title = "Batanopride (BMY-25801): A new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis",
author = "L. Smaldone and P. Plezia and Alberts, {David S} and M. Aapro and G. Sartiano and M. Dorn and M. Brady and C. Comerski and Schwartz, {S. E.} and C. Fairchild and R. Canetta and M. Rozencweig",
year = "1990",
doi = "10.1016/0305-7372(90)90064-M",
language = "English (US)",
volume = "17",
pages = "319--327",
journal = "Cancer Treatment Reviews",
issn = "0305-7372",
publisher = "W.B. Saunders Ltd",
number = "2-3",

}

TY - JOUR

T1 - Batanopride (BMY-25801)

T2 - A new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis

AU - Smaldone, L.

AU - Plezia, P.

AU - Alberts, David S

AU - Aapro, M.

AU - Sartiano, G.

AU - Dorn, M.

AU - Brady, M.

AU - Comerski, C.

AU - Schwartz, S. E.

AU - Fairchild, C.

AU - Canetta, R.

AU - Rozencweig, M.

PY - 1990

Y1 - 1990

UR - http://www.scopus.com/inward/record.url?scp=0025614502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025614502&partnerID=8YFLogxK

U2 - 10.1016/0305-7372(90)90064-M

DO - 10.1016/0305-7372(90)90064-M

M3 - Article

C2 - 2272047

AN - SCOPUS:0025614502

VL - 17

SP - 319

EP - 327

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

SN - 0305-7372

IS - 2-3

ER -